NICE looks set to back ‘triple therapy’ diabetes drug
The National Institute for Health and Care Excellence has provisionally recommended dapagliflozin for treating type 2 diabetes in “triple therapy”.
Source: Nursing Times - Category: Nursing Source Type: news
More News: Dapagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Forxiga | Health | National Institute for Health and Clinical Excelle | Nurses | Nursing